Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)
Clinical trial NCT05045508 · UNKNOWN
Trial details
- NCT number
- NCT05045508
- Sponsor
- Brandon Baartman
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2022-08-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.